Urologic Design Secues $1.2M in Pre-Seed Funding

Urologic Design, a Branford, CT-based medical device provider for managing urinary incontinence, has raised $1.2 million in a Pre-Seed funding round.

The round was led by Angel Investor Forum with participation from HBS Alumni Angels of Boston, Haven Founders Fund, Connecticut Innovations, Yale Angels, and individual investors.

The company will use the funding to advance its first product, continue research and development, complete regulatory work, and prepare for an initial clinical study.

What is Urologic Design?

Urologic Design develops medical devices for managing stress urinary incontinence, a condition that causes urine leakage during activities such as coughing, sneezing, or physical movement.

Read More:Opentrons Labworks Secures $40M in Series E Funding

The company aims to offer an additional option for men dealing with stress urinary incontinence. Its current work focuses on refining and testing the device before moving into clinical studies.

How Much Funding Has Urologic Design Raised?

Urologic Design has raised $1.2 million in its pre-seed funding round. The company has not disclosed details of any previous funding rounds or its total funding raised to date.

The latest funding will support product development, research, regulatory activities, and preparation for its first clinical study.

Who Invested in Urologic Design’s Pre-Seed Round?

The $1.2 million pre-seed round was led by Angel Investor Forum.

Other participating investors include:

• HBS Alumni Angels of Boston
• Haven Founders Fund
• Connecticut Innovations
• Yale Angels
• Individual investors

Why the Funding Matters

The funding will help Urologic Design move its first medical device closer to clinical evaluation.

The company has already developed a working prototype, secured intellectual property protection and completed extensive bench testing. The new capital will support further product refinement and testing, along with the regulatory work required before human studies.

Who founded Urologic Design?

Urologic Design was founded in 2022 by Henry Ritter and David Hesse. The company is based in Branford, Connecticut.

The founders are developing a patented medical device designed to provide temporary management of stress urinary incontinence in men.

"AIF invests in companies addressing meaningful unmet needs with differentiated solutions," said Matthew Stannard, Life Sciences Lead at Angel Investor Forum. "Urologic Design impressed us with its approach to bridging the gap between absorbent products and surgery for managing urinary incontinence.

"For the 25 million people living with urinary incontinence in the United States, the available options are uncomfortable, cumbersome, and difficult to incorporate into everyday life," says Dr. David Hesse, Co-Founder and Chief Scientific Officer of Urologic Design. "

Market and Business Growth

Urologic Design has developed a working prototype of its urethral occlusion device, and secured intellectual property protection. It has also completed extensive bench testing.

The company is now preparing for an initial clinical study involving a small group of men with stress urinary incontinence in the United States.

What Happens Next?

Urologic Design plans to continue refining and testing its first product while completing the necessary regulatory work.

The company will also prepare for its first-in-human clinical study involving a small cohort of men in the United States. The study will be an important step in evaluating the device before further development.

Read More:AI Startup Dream Secures $17M in Seed Funding